0085-1328 : Noxafil 40 mg/ml Oral Suspension
NDC: | 0085-1328 |
Labeler: | Merck Sharp & Dohme Corp. |
Product Type: | Human Prescription Drug |
Drug Name: | Noxafil |
Dosage Form: | Oral Suspension |
Application #: | NDA022003 |
Rev. Date: |
NDC Package Codes:
- 0085-1328-01: 1 BOTTLE, GLASS IN 1 CARTON (0085‑1328‑01) > 105 ML IN 1 BOTTLE, GLASS
Active Ingredients:
- Posaconazole
Dosage Strength:
- 40 mg/mL
Pharmaceutical Classes:
- Azole Antifungal [EPC]
- Azoles [CS]
Related Products:
Based on records with the same trade name.- 0085-2224 Noxafil 300 mg Oral Powder, for Suspension by Merck Sharp & Dohme Corp.
- 0085-4324 Noxafil 100 mg/1 Oral Tablet, Coated by Merck Sharp & Dohme Corp.
- 0085-4331 Noxafil 18 mg/ml Intravenous Solution by Merck Sharp & Dohme Corp.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0085-1323Next: 0085-1334 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.